-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Hvx1beIHzCvHR/a3CQbaYESt0TbPjK+B0bJ7mPdLg7T+9NvegfbENbDh8nPgHhnC
 kRVnkpWvN6qiSJRIn3EANg==

<SEC-DOCUMENT>0000950123-08-006605.txt : 20080605
<SEC-HEADER>0000950123-08-006605.hdr.sgml : 20080605
<ACCEPTANCE-DATETIME>20080605123527
ACCESSION NUMBER:		0000950123-08-006605
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20080605
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20080605
DATE AS OF CHANGE:		20080605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MILESTONE SCIENTIFIC INC/NJ
		CENTRAL INDEX KEY:			0000855683
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				133545623
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14053
		FILM NUMBER:		08882444

	BUSINESS ADDRESS:	
		STREET 1:		220 S ORANGE AVE
		STREET 2:		LIVINGSTON CORPORATE PARK
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039
		BUSINESS PHONE:		2013793171

	MAIL ADDRESS:	
		STREET 1:		44 KEAN ROAD
		STREET 2:		220 SOUTH ORANGE AVE
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	U S OPPORTUNITY SEARCH INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>y60087e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>FORM 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>Pursuant to Section&nbsp;13 or 15(d) of the<BR>
Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported) </B><U><B>June&nbsp;5, 2008</B></U></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B><FONT style="border-bottom: 1px solid #000000">MILESTONE SCIENTIFIC INC.</FONT></B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>(Exact name of Registrant as specified in its charter)</B></DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>0-26284</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>13-3545623</B></TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>(State or other jurisdiction</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>(Commission</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>(IRS Employer</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>of incorporation)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>File Number)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Identification No.)</B></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><FONT style="border-bottom: 1px solid #000000"><B>220 South Orange Avenue, Livingston Corporate Park, Livingston, New Jersey 07034</B></FONT></DIV>

<DIV align="center" style="font-size: 10pt"><B>(Address of principal executive office) (Zip Code)</B></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Registrant&#146;s telephone number, including area code </B><U><B>(973)&nbsp;535-2717</B></U></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>N/A</B></DIV>

<DIV align="center" style="font-size: 10pt"><DIV style="margin-top: 1px"><FONT style="border-top: 1px solid #000000"><B>(Former name or former address, if changed since last report)</B></FONT></DIV></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!--TOC-->
<!--/TOC-->




<!-- link1 "Item&nbsp;7.01: Regulation&nbsp;FD Disclosure." -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;7.01: Regulation&nbsp;FD Disclosure.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;5, 2008, at its Annual Meeting of Shareholders, Milestone Scientific, Inc.
(&#147;Milestone&#148;) announced its entry into a Distributorship Agreement with Patterson Dental Holdings,
Inc. (&#147;Patterson&#148;), a subsidiary of Patterson Companies, Inc., to market and sell on a
non-exclusive basis the <I>STA</I><SUP style="font-size: 85%; vertical-align: text-top"><I>&#153;</I></SUP><I> System</I>, Milestone&#146;s patented, award-winning, painless
dental injection system, and related disposable hand pieces to dental professionals in the United
States and Canada. Patterson is a national distributor of dental products with the largest direct
sales force in the United States and Canadian markets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of the press release announcing Milestone&#146;s addition of Patterson to its distribution
network is furnished as Exhibit&nbsp;99.1 hereto. This information shall not be deemed &#147;filed&#148; for
purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and
shall not be deemed to be incorporated by reference into any filing of Milestone under the
Securities Act of 1933, as amended, or the Exchange Act.
</DIV>
<!-- link1 "Item&nbsp;9.01: Financial Statements and Exhibits" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01: Financial Statements and Exhibits</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Exhibits:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="82%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated June&nbsp;5, 2008.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<!-- link1 " SIGNATURES" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>MILESTONE SCIENTIFIC INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Joe W. Martin
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Joe W. Martin&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: June&nbsp;5, 2008
</DIV>


<P align="right" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>y60087exv99w1.htm
<DESCRIPTION>EX-99.1: PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;99.1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>MILESTONE SCIENTIFIC EXPANDS U.S. AND CANADIAN DISTRIBUTION<BR>
NETWORK WITH ADDITION OF PATTERSON DENTAL SUPPLY</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B><I>LIVINGSTON, N.J. &#150; (PR NEWSWIRE) &#150; June&nbsp;5, 2008 </I></B>&#150; Milestone Scientific Inc. (OTCBB:MLSS), the
recognized leader in advanced injection technologies, today announced that it has expanded its U.S.
and Canadian distribution network with the addition of Patterson Dental Supply, a division of
Patterson Companies, Inc. (Nasdaq:PDCO).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Patterson Dental Supply has the largest direct sales force in the industry, totaling approximately
1,400 sales representatives and equipment/software specialists serving the United States and
Canada. Patterson will join Henry Schein, Inc. (Nasdaq:HSIC), the largest distributor of
healthcare products and services to office-based practitioners in the combined North American and
European markets, to both market and sell on a non-exclusive basis the <I>STA</I><SUP style="font-size: 85%; vertical-align: text-top">&#153;</SUP><I> System</I>,
Milestone&#146;s patented, award-winning, painless dental injection solution, and related disposable
hand pieces to dental professionals in the United States and Canada.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Joe Martin, Chief Executive Officer of Milestone, stated &#147;By leveraging the marketing muscle,
reputational reach and influence of the two largest dental suppliers in the industry, Milestone
looks forward to achieving the market penetration necessary to drive broad adoption of the <I>STA
System </I>as the new standard of care for dental injections. Moreover, as we persist in building our
global distribution network, the further addition of strategic distribution partners in key
international markets will aid us in promoting potentially profound sales growth from the worldwide
marketing of the <I>STA System</I>. We are very pleased to welcome the Patterson organization to our team
and appreciate that they share our enthusiasm and expectations for Milestone and our innovative
technological solutions.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The state-of-the-art <I>STA System </I>is Milestone&#146;s latest achievement in computer-controlled local
anesthesia delivery (CCLAD)&nbsp;that makes the injection process more comfortable for both dentists and
patients. Marketed for use by dental practitioners to painlessly administer all dental injections,
the <I>STA System </I>is uniquely capable of administering &#147;Single Tooth Anesthesia&#148; into the Periodontal
Intraligamentary (PDL)&nbsp;space, something never before possible using conventional techniques.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About Patterson Companies, Inc.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet
veterinarian and rehabilitation supply markets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Dental Market</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">As Patterson&#146;s largest business, Patterson Dental provides a virtually complete range of consumable
dental products, equipment and software, turnkey digital solutions and value-added services to
dentists and dental laboratories throughout North America.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Veterinary Market</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Webster Veterinary is the nation&#146;s second largest distributor of consumable veterinary supplies,
equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet
veterinary clinics.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>Rehabilitation Market</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Patterson Medical is the world&#146;s leading distributor of rehabilitation supplies and non-wheelchair
assistive patient products to the physical and occupational therapy markets. The unit&#146;s global
customer base includes hospitals, long-term care facilities, clinics and dealers.
</DIV>



<P align="right" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>About Henry Schein, Inc.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Henry Schein, a <I>Fortune 500</I><SUP style="font-size: 85%; vertical-align: text-top"><I><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></I></SUP> company and a member of the NASDAQ 100<SUP style="font-size: 85%; vertical-align: text-top"><I><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP></I></SUP> Index,
is recognized for its excellent customer service and highly competitive prices. The Company&#146;s four
business groups &#151; Dental, Medical, International and Technology &#151; serve more than 550,000 customers
worldwide, including dental practitioners and laboratories, physician practices and animal health
clinics, as well as government and other institutions. The Company operates through a centralized
and automated distribution network, which provides customers in more than 200 countries with a
comprehensive selection of more than 90,000 national and Henry Schein private-brand products in
stock, as well as more than 100,000 additional products available as special-order items.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Headquartered in Melville, N.Y., Henry Schein employs over 12,000 people and has operations or
affiliates in 20 countries. The Company&#146;s net sales reached a record $5.9&nbsp;billion in 2007. For more
information, visit the Henry Schein Web site at www.henryschein.com.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About Milestone Scientific Inc.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary,
highly innovative technological solutions for the medical and dental markets.&nbsp; Central to the
Company&#146;s IP platform and product development strategy is its patented <I>CompuFlo</I><SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>
technology for the improved and painless delivery of local anesthetic. Specifically, <I>CompuFlo </I>is a
computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology,
which provides real-time readouts of pressures, fluid densities and flow rates, enabling the
advanced delivery and removal of a wide array of fluids.&nbsp; The <I>STA</I><SUP style="font-size: 85%; vertical-align: text-top">&#153;</SUP> (Single Tooth
Anesthesia) <I>System </I>computer-controlled local anesthesia delivery system which uses this technology
provides dentists with audible and visual signals as to in-tissue pressure.&nbsp; Milestone&#146;s existing
painless injection systems are currently sold in 25 countries. For more information on these and
other innovative Milestone products, please visit the Company&#146;s Web sites found at <u>www.milesci.com</u>
and <u>www.STAis4U.com</u>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B><I>Safe Harbor Statement</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>This press release contains forward-looking statements regarding the timing and financial impact of
the Milestone&#146;s ability to implement its business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are based on assumptions involving
judgments with respect to future economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict accurately and many of which are
beyond Milestone&#146;s control. Some of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements are general economic conditions,
failure to achieve expected revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time in Milestone&#146;s periodic
filings with the Securities and Exchange Commission, including without limitation, Milestone&#146;s
Annual Report on Form 10-KSB for the year ended December&nbsp;31, 2007. The forward looking-statements
in this press release are based upon management&#146;s reasonable belief as of the date hereof.
Milestone undertakes no obligation to revise or update publicly any forward-looking statements for
any reason.</I>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>FOR MORE INFORMATION, PLEASE CONTACT:<BR>
Elite Financial Communications Group/Elite Media Group<BR>
Dodi Handy, President and CEO<BR>
407-585-1080 or via email at </B><B><I>mlss@efcg.net</I></B>

</DIV>


<P align="right" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
